How gestational diabetes affects brain blood flow after pregnancy
Official title: The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
Run by University of Iowa · NCT06911372 · Data updated 2026-11-12
This study will test whether a past diagnosis of gestational diabetes changes brain blood flow and blood-vessel function in women within five years after giving birth.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 84 (estimated) |
| Sponsor | University of Iowa Academic / other |
| Locations | 1 site (Iowa City, Iowa) |
| Status | Recruiting |
| Started | August 22, 2025 |
| Main results expected | April 15, 2027 |
| Study ends | April 15, 2028 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT06911372 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy postpartum women aged 18 or older who delivered within five years and either had gestational diabetes diagnosed by standard criteria or had an uncomplicated pregnancy, and who do not have current diabetes or other excluded conditions or medications.
✕Probably not a fit
Women with current diabetes, active hepatic/metabolic/lung disease, diagnosed mood disorders, current tobacco use, significant skin disease, or who take excluded medications are unlikely to be eligible or to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare healthy postpartum women with a history of gestational diabetes to those with an uncomplicated pregnancy using noninvasive cerebral blood flow measurements and targeted microvascular testing. The protocol uses two types of ultrasound to measure cerebral hemodynamics and intradermal microdialysis with local heating to probe peripheral microvascular function as a mechanistic correlate. Participants must be at least 18 years old, delivered within the past five years, and free of current diabetes or several excluded medical conditions and medications. This Phase 1 interventional protocol is focused on physiological measurements to characterize cerebrovascular changes after gestational diabetes rather than testing a therapeutic intervention.
Why it matters
Potential benefit: If successful, the findings could reveal vascular changes after gestational diabetes that inform strategies to reduce later stroke and dementia risk.
How similar studies have gone: Prior studies have shown impaired skin microvascular function after gestational diabetes and ultrasound has been used to study cerebral blood flow in other populations, but applying these cerebrovascular tests specifically to postpartum GDM is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: * Post-partum women * 18 years or older * Delivered within 5 years from the study visit * History of gestational diabetes diagnosed by an obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes OR history of uncomplicated pregnancy (defined as no history of gestational diabetes, hypertensive pregnancy, or other gestational disorder). EXCLUSION CRITERIA: We exclude participants from both groups for: * Skin diseases * Current tobacco use * Diagnosed or suspected hepatic or metabolic disease including diabetes * Diagnosed with depression or other mood-related disorders, asthma, chronic obstructive pulmonary disease, cystic fibrosis, or pulmonary fibrosis * Use of prescribed NSAIDs, statins or other cholesterol-lowering medication, antihypertensive medication, carbonic anhydrase inhibitors, corticosteroids, thyroid medications, antidepressants or mood stabilizers, diuretics, phenothiazines, or benzodiazepines * History of preeclampsia or gestational hypertension, * History or family history of panic disorder, * Currently pregnant * Body mass index \<18.5 kg/m2, * Allergy to materials used during the experiment (e.g. latex), known allergies to study drugs. * History of heavy alcohol use/binge drinking, * Have planned procedures with radiological contrast, * Have a major dental procedure/surgery coming up, such as a dental extraction * Anatomy of the middle cerebral artery or internal carotid artery that prevents adequate ultrasonography and/or and data collection
Where it's running
-
Iowa Bioscience Innovation Facility
Iowa City, Iowa, United States Recruiting
Study contacts
- Study coordinator: Anna Reid-Stanhewicz, PHD
- Email: anna-stanhewicz@uiowa.edu
- Phone: 319-467-1732
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Metformin vs glyburide for blood sugar in gestational diabetes
This study tests whether metformin or glyburide better controls blood sugar in pregnant women with gestational diabetes who need oral medication.
-
Quality of life and psychological factors in women with gestational diabetes
This study tests how gestational diabetes affects quality of life and stress or anxiety in pregnant women treated at a hospital in Ludhiana.
-
Myo-Inositol for Glycemic Control in Gestational Diabetes
This study tests whether taking myo-inositol with folic acid can improve blood sugar control and reduce inflammation in pregnant people with gestational diabetes.
-
Daily kefir during mid-pregnancy to see if it helps prevent gestational diabetes
Pregnant people will drink kefir daily from mid-pregnancy to see if it improves blood sugar and insulin, reduces gestational diabetes risk, and positively affects gut bacteria.
-
Protective effect of lactation on gestational diabetes in a future pregnancy
This observational study tests whether lactation around the time of a first pregnancy is linked to a lower risk of gestational diabetes in a subsequent pregnancy for women who conceive while lactating.
-
Natural cervical ripening to delay pharmacological induction of labor
This pilot study tests whether nipple stimulation and membrane sweeping can help some pregnant people go into labor on their own without needing drugs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.